but has yielded information on the immune repertoire diversities of several donors. The results indicate that immune human donors develop predominant repertoire patterns to select Pseudomonas antigens, including two proteases secreted by the organism.
Materials and Methods
Cell Preparations. Mononuclear cells (MC) were isolated from the blood of healthy adult immune donors by centrifugation through Hypaque-Ficoll. Adherent monocytes (M~) were prepared as previously described (13) , except that M~s were irradiated (2,500 rad; 137Cs) rather than being treated with mitomycin.
Antigens. Crude Pseudomonas antigens consisted of sterile (0.22 #m Millipore filtered) culture supernatant fluids collected after 48 h of bacterial growth in trypticase soy broth. The bacterial growth medium was not antigenic for human T cells. Crude antigens were titrated against at least five immune donors' MCs for optimum tissue culture doses, (generally found to be 0.1-1 # 1/well). Pseudomonas alkaline protease (AP) and elastase (E) were purchased from Nagase Co, Ltd. (Tokyo) and Pseudomonas exotoxin A was prepared as previously described (14) . Inactivation of the enzyme activity of AP involved heating at 65 °C for 30 min (15, 16) . Total protease activity was measured by the assay described by Rinderknecht et al. (17) using hide azure blue powder suhstrate, and elastolytic activity was determined as previously described (18) . Mumps, tuberculin PPD, and Candida albicans were purchased from commercial sources and used at doses reported earlier (13) .
Cloning of Pseudoraonas-specific Human T Cells. Screening MC donors for immunity to Pseudomonas involved culturing MC with various Pseudomonas antigens (Table I) under conditions previously described (13) and assessing tritiated thymidine ([SH]TdR) uptake 7 d later. Donors were designated highly immune if the stimulation index, SI (cpm, antigen-stimulated cultures/cpm, control cultures) was >1'0.
Monoclonal T cell populations were isolated and propagated according to Lamb et al. (19) with the following modifications. All cloning and assay medium contained 10% human AB + serum. After initial stimulation with crude Pseudomonas antigens for 6 d, lymphoblasts were purified by a two-step (35%, 45%) discontinuous Percoll gradient and plated under limiting dilution conditions (30-40 wells/dose) in Teresaki Microtest II plates (Falcon Labware, Oxnard, CA). Input cell doses ranged from 27 to 0.11 lymphoblasts/well. After 7 d, the contents of each well were transferred to a 200 #1 microculture and expanded for 7 additional days in the presence of 10-20% TCGF, antigen, and l0 s (22) , they failed to produce detectable amounts of AP when grown in TSB under the conditions used for this study.
irradiated, autologous MC. Wells then were scored for growth and Poisson analysis was used to identify those populations arising from single precursors (i.e., input cell doses giving >37% negative wells). Clones were expanded in 15-mm wells containing antigen, 10% TCGF, and 106 autologous irradiated (2,500 rad, ~3~Cs) MC as feeder cells. Subcloning was performed in an analogous fashion on clones aa6, aa 10, if1, and dd3 (see Fig. 1 ) using an input cell dose of 0.33 cells/well and in all cases verified monoclonality. Typically, two passages (3-4 d each) in 15-mm wells were adequate to expand clones and subclones to populations of >2 x l0 T cells, at which time they were frozen (-80°C) in cloning medium containing 7.5% dimethyl sulfoxide. Subsequent expansion, when necessary, was always performed with autologous irradiated MC, antigen, and 10-20% TCGF. TCGF was prepared by stimulating tonsillar lymphocytes (108/ml) in 12-mm polystyrene tubes with 0.1% PHA-P (Difco Laboratories Inc., Detroit, MI); the reagent was diluted to a concentration of 10 mg/ml according to the manufacturer's instructions and further diluted 1:100 in culture medium). Culture supernatant fluids were recovered 48 h later, filter sterilized, and used without further purification.
In Vitro Antigen-induced T Cell Proliferation. Specificity assays with uncloned MC (105] well) were performed in 96-well flat-bottom plates as previously described (13) . To determine the specificity of cloned T cell populations, the cells were thawed, washed three times, and cultured (1-2 X 104/well) with irradiated (2,500 rad), autologous adherent MSs (10~/well) and various antigens in 200-#I flat-bottom wells. Generally, better responses were obtained when the MSs were precuhured with antigen for 16-18 h before addition of the T cell clones to the wells. All specificity assays were performed with cloning medium (19) Table I ). The patterns are clustered so as to achieve maximum homology and are assigned specificities that reflect, where possible, reactivity with purified Pseudoraonas exoproducts. A positive reaction is one in which [SH]TdR uptake exceeded control levels by a factor of 10. Results To assure that a wide range of potential Pseudomonas antigens could be examined, we prepared crude culture supernatant fluids from nine mucoid strains, three recovered from cystic fibrosis patients and six that previously had been characterized for their pathogenicity and secreted exoproducts (13, 18, (20) (21) (22) . Some of the known attributes of these bacterial strains are shown in Table I . Of particular interest were those strains that failed to secrete proteases or toxins, because these would be useful in implicating specific products as T cell antigens.
The antigen preparations were then used to stimulate blood MC from a large number of immune donors. Results with six representative donors (Table II) revealed that most of the preparations were highly mitogenic. Additional experiments not reported here showed that proliferative responses were adherent cell dependent, reached maximum levels on days 6-7 of culture, and were mediated by E rosette-forming lymphocytes. -20% of the normal donors tested showed reactivity to one or more of the antigens listed in Table II . Only an occasional donor was immune to the protease-deficient Pa-103 preparation, whereas the majority of immune donors responded to PAO-1 (a normal protease-producing strain). This implied that one or more of the Pseudoraonas proteases was a common antigen.
In an attempt to identify the bacterial antigens responsible for this activity, T cells from donors 1 and 2 (Table II) were selected with the GoM or JoS antigens and cloned by limiting dilution. Limiting dilution cloning after only 6 d of in vitro stimulation assured recovery of a large number of clones with diverse antigen specificities.
Monoclonal populations were then expanded with a minimum number of passages (usually only 3) to large numbers (~2 x 107) and frozen in dimethyl sulfoxide-containing medium. Aliquots were later thawed, washed, and assayed for specificity in the presence of freshly prepared autologous antigen-presenting MSs. 29 clones were initially isolated from these two donors and tested for specificity. Approximately half (i.e., 14) were unreactive or very weakly reactive to Pseudomonas antigens in the absence of TCGF. 15 Pseudomonas-specific clones were identified that reacted (SI > 10) with the antigens listed in Table I . None of these T cells responded to antigens in the absence of MSs. Fig. 1 shows those reactions that were useful in distinguishing between different clones. The figure also groups the clones into five subsets, presumably representing distinct antigenic determinants (here designated AP-1, AP-2, AP-3, E, and PAX). 12 clones reacted with purified Pseudomonas alkaline protease (AP) and two of these showed a weak cross-reactivity with elastase (E). One clone (f6) reacted selectively with elastase (E). Three distinct AP determinants were implied by the data and these together constituted the most frequent specificities. For example, determinant AP-1 was present in both GoM and JoS crude antigens and on the purified AP molecule. By contrast, AP-3 was present on pure AP and in the crude JoS preparation, but was lacking in the GoM crude antigen.
A titration of AP against clone GoMaa6 as well as the donor's uncloned MCs revealed that AP was antigenic at very low concentrations (~1 ng/ml) and stimulated vigorous proliferative responses (Fig. 2) . These responses were adherent cell dependent and could be elicited with AP-pulsed M$s (data not shown).
Since the antigen AP was proteolytic, we wanted to exclude the possibility that its mitogenicity was dependent simply on its enzymatic activity. Heat treatment of the enzyme (65°C for 30 min) reduced caseinolytic activity 1,600-fold, but only partially affected antigenicity (Fig. 3) . Proliferative responses to AP were suboptimal at doses >10 -I #g/well and declined to background levels when doses were increased above 1 #g/well. This inhibition was apparently attributable to enzyme-dependent toxicity, because heat inactivation of the protein reversed the effect. Moreover, addition of high doses of AP to mumps-stimulated cultures inhibited anti-mumps responses as well (Fig. 4) . Here too, the immunosuppressive effect was reversed when the AP was first heat treated.
The finding that so many clones from these two donors were AP specific implied that immunity to the protease might be common among Pseudomonasimmune donors. Indeed, four of the six donors included in this study were highly immune to the antigen (Table III) (Fig. 5) revealed that the frequencies of AP-specific proliferating T cells were comparable to the frequencies of T cells committed to all secreted Pseudomonas antigens in the crude PAO-1 preparation. This was a consistent finding (Table  IV) . The frequencies obtained were also comparable to those calculated for T cells reacting to non-Pseudomonas antigens (e.g., mumps antigen, exp. 5; references 23, 24) . Values for y-intercepts (y = 0.84-1.06) indicated that a single precursor cell type was being titrated.
As a final test of the hypothesis that most of the T cells of these donors were reacting to AP secreted by Pseudomonas organisms, we cloned cells from donor 5 (Table III) , using AP as the selecting antigen. We predicted that clones obtained in this manner should show specificity for AP and express the same specificity for the crude antigen panel (Fig. 1) as did the AP-specific clones initially selected with crude antigens. This was indeed the case. Table V summarizes data on six such clones. Five showed reactivity to the GoM, JoS, PAO-1, and AP antigens, while failing to respond to the Ka, Pa-103, or E antigens (i.e., they were AP-1 specific; see Fig. 1 ). Therefore, by selecting clones with either pure AP or crude Pseudomonas antigens, we obtained T cells with the same apparent specificities. port this conclusion. First, soluble crude antigens prepared from Pseudomonas strains that were known to produce little or no protease (e.g. Pa-103, Pa-103-29, and PAO-1-1641; reference 22 and Howe and Iglewski, unpublished observations) have consistently failed to stimulate MCs from most donors tested to date. This did not appear to reflect nonspecific toxicity of the preparations, since they did not inhibit MC responses to non-Pseudomonas antigens. Second, monoclonal T cells selected for reactivity to soluble crude Pseudomonas antigens reacted specifically with purified AP at fairly low doses (10-1-10 -5 t~g/ml). Pure AP also stimulated uncloned MC from four of the six donors included in this report. Third, when absolute measurements of the frequencies of AP-specific blood T cells were made, we found that these were not trivial clones that had simply survived the pressures of in vitro selection. Rather, their numbers among uncloned cell populations were comparable to the frequencies of T cells committed to all released Pseudomonas antigens of the JoS and PAO-1 strains. These values (1/67,454-1/37,090 MC) are also comparable to published data on the frequencies of human blood T cells specific for streptokinase-steptodornase, tetanus toxoid, tuberculin PPD, and keyhole limpet hemocyanin (23) (24) (25) (26) . It should be noted, however, that frequencies calculated in this manner represent minimum values, particularly for the crude antigens that contain inhibitory substances, such as endotoxin, that might interfere with the detection of antigenreactive T cells (13) . Finally, we selected clones from Pseudomonas-immune donors with AP and re-tested these for reactivity against the panel of crude antigens. Clones with the same specificity patterns were obtained regardless of whether they were selected with crude or purified AP antigens.
We have considered the possibility that the purified AP used in this study was contaminated with another antigen, particularly Pseudomonas E. However, direct measurements of the two enzyme activities have detected <0.1% E contamination of the AP preparation. Three additional observations argue against E contaminating the AP. First, very small quantities of purified AP were antigenic for many of the clones (e.g., 10 -2 ng/ml), whereas elastase-specific clones, like f6, typically showed optimal responses at doses of 10-2-10 -~ #g E/ml. Therefore, a minor E contaminant in the AP probably would have been insufficient to activate the cells. Second, at least one strain of bacteria included in this study (Ka) produced very high levels of E but was nonantigenic for AP-specific clones. Third, although two AP-2 specific clones cross-reacted with E, responses to E were modest (i.e., mean cpm [3H]TdR uptake for AP and E were approximately 42,000 and 6,000, respectively). This is not to say that Pseudomonas E is not an important antigen. In fact, clone f6 (Fig. 1) , which did not react with AP, reacted vigorously with crude Ka antigen and pure E. Recent analysis of cells from donor 6 (Table II) selected with the PAO-1 antigens has revealed a preponderance of E-specific clones (data not shown).
A number of observations reported here can be explained by postulating that allotypic variations exist between the proteases produced by different Pseudomonas strains. For example, clone aa6 recognized a determinant (designated AP-1) present on AP molecules secreted by GoM and JoS strains. By contrast, the AP produced by the GoM strain apparently lacked the AP-3 determinant (Fig.  1) . The presence of allotypic markers capable of distinguishing between different Pseudomonas strains suggests that T cell clones may prove useful as monoclonal typing reagents in defining antigens associated with pathogenicity traits. Alkaline protease has been implicated in animal models as a virulence factor in Pseudomonas infections (12, (27) (28) (29) (30) (31) , although to our knowledge allotypic variants of the molecule have not heretofore been described. Such information may prove important in identifying bacterial properties and altered host immune responses that permit chronic Pseudomonas infections like those in CF. In this regard it is significant that CF patients' blood MC failed to mount proliferative response to Ka and JoS crude antigens despite ongoing pulmonary Pseudomonas infections. 2 Because CF patients are known to produce antibodies to AP and E (3), these findings suggest that protease-specific T cells may be involved in limiting such infections.
Summary
To aid in understanding the role of cellular immunity in limiting Pseudoraonas aeruginosa infections, we have identified some of the principal antigens of the organism that are recognized by human T cells. Clones of T cells were selected in such a manner that they would provide information not only about the identity of Pseudomonas antigens, but also the T cell repertoires of immune donors. Most clones were found to be specific for Pseudoraonas alkaline protease (AP). Such clones could be physically isolated by selecting with crude Pseudoraonas antigens or purified AP. In either case, their fine specificities were the same when tested against a panel of Pseudomonas antigens. The conclusion that AP is the principal immunogen for many donors was confirmed by measuring the absolute frequencies of proliferating T cells committed to AP and all other Pseudoraonas antigens. Frequencies of AP-specific clones (1.5-2.7 x 10 -5) were comparable to those from the same donors that were specific for all secreted Pseudomonas antigens (1.3-6.0 x 10-5). These results provide a model system for studying human T cell-mediated immunity to bacteria by identifying discrete antigens and measuring the repertoire diversities of cells responding to them.
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